Our results support the assumption that smaller FMR1 gene expansions are also associated with the risk of developing neurological signs, in particular also female patients should be considered in the diagnostic practice for FXTAS. The gene discussed is FMR1; the disease is fragile X-associated tremor/ataxia syndrome.